These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 12069173)
1. Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro. Na K; Bae YH Pharm Res; 2002 May; 19(5):681-8. PubMed ID: 12069173 [TBL] [Abstract][Full Text] [Related]
2. Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. Na K; Lee ES; Bae YH J Control Release; 2003 Feb; 87(1-3):3-13. PubMed ID: 12618018 [TBL] [Abstract][Full Text] [Related]
3. pH-sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate. Na K; Lee KH; Bae YH J Control Release; 2004 Jul; 97(3):513-25. PubMed ID: 15212883 [TBL] [Abstract][Full Text] [Related]
4. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). Na K; Park KH; Kim SW; Bae YH J Control Release; 2000 Nov; 69(2):225-36. PubMed ID: 11064130 [TBL] [Abstract][Full Text] [Related]
5. Self-assembled polymeric nanoparticles of poly(ethylene glycol) grafted pullulan acetate as a novel drug carrier. Jung SW; Jeong YI; Kim YH; Kim SH Arch Pharm Res; 2004 May; 27(5):562-9. PubMed ID: 15202564 [TBL] [Abstract][Full Text] [Related]
6. High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting. Li H; Bian S; Huang Y; Liang J; Fan Y; Zhang X J Biomed Mater Res A; 2014 Jan; 102(1):150-9. PubMed ID: 23613258 [TBL] [Abstract][Full Text] [Related]
7. pH-responsive injectable hydrogels with mucosal adhesiveness based on chitosan-grafted-dihydrocaffeic acid and oxidized pullulan for localized drug delivery. Liang Y; Zhao X; Ma PX; Guo B; Du Y; Han X J Colloid Interface Sci; 2019 Feb; 536():224-234. PubMed ID: 30368094 [TBL] [Abstract][Full Text] [Related]
8. pH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells. Guo H; Liu Y; Wang Y; Wu J; Yang X; Li R; Wang Y; Zhang N Carbohydr Polym; 2014 Oct; 111():908-17. PubMed ID: 25037431 [TBL] [Abstract][Full Text] [Related]
9. Efficient Delivery of DOX to Nuclei of Hepatic Carcinoma Cells in the Subcutaneous Tumor Model Using pH-Sensitive Pullulan-DOX Conjugates. Li H; Cui Y; Sui J; Bian S; Sun Y; Liang J; Fan Y; Zhang X ACS Appl Mater Interfaces; 2015 Jul; 7(29):15855-65. PubMed ID: 26140410 [TBL] [Abstract][Full Text] [Related]
10. Dual-pH/Magnetic-Field-Controlled Drug Delivery Systems Based on Fe Hu X; Wang Y; Zhang L; Xu M; Zhang J; Dong W ChemMedChem; 2017 Oct; 12(19):1600-1609. PubMed ID: 28857472 [TBL] [Abstract][Full Text] [Related]
11. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin. Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730 [TBL] [Abstract][Full Text] [Related]
12. Physicochemical characteristics of Fe3O4 magnetic nanocomposites based on Poly(N-isopropylacrylamide) for anti-cancer drug delivery. Davaran S; Alimirzalu S; Nejati-Koshki K; Nasrabadi HT; Akbarzadeh A; Khandaghi AA; Abbasian M; Alimohammadi S Asian Pac J Cancer Prev; 2014; 15(1):49-54. PubMed ID: 24528080 [TBL] [Abstract][Full Text] [Related]
13. Polyethylene sebacate doxorubicin nanoparticles: role of carbohydrate anchoring on in vitro and in vivo anticancer efficacy. Pranatharthiharan S; Patel MD; Malshe VC; Devarajan PV Drug Deliv; 2016 Oct; 23(8):2980-2989. PubMed ID: 26786706 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers. Raja MA; Arif M; Feng C; Zeenat S; Liu CG J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668 [TBL] [Abstract][Full Text] [Related]
15. Smart nanoparticles based on pullulan-g-poly(N-isopropylacrylamide) for controlled delivery of indomethacin. Constantin M; Bucătariu S; Stoica I; Fundueanu G Int J Biol Macromol; 2017 Jan; 94(Pt A):698-708. PubMed ID: 27773840 [TBL] [Abstract][Full Text] [Related]
16. Self-assembled phytosterol-fructose-chitosan nanoparticles as a carrier of anticancer drug. Qiu Y; Zhu J; Wang J; Gong R; Zheng M; Huang F J Nanosci Nanotechnol; 2013 Aug; 13(8):5935-41. PubMed ID: 23882863 [TBL] [Abstract][Full Text] [Related]
17. Nanostructure controlled sustained delivery of human growth hormone using injectable, biodegradable, pH/temperature responsive nanobiohybrid hydrogel. Singh NK; Nguyen QV; Kim BS; Lee DS Nanoscale; 2015 Feb; 7(7):3043-54. PubMed ID: 25603888 [TBL] [Abstract][Full Text] [Related]
18. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery. Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075 [TBL] [Abstract][Full Text] [Related]
19. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy. Qu J; Zhao X; Ma PX; Guo B Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902 [TBL] [Abstract][Full Text] [Related]
20. Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Na K; Bum Lee T; Park KH; Shin EK; Lee YB; Choi HK Eur J Pharm Sci; 2003 Feb; 18(2):165-73. PubMed ID: 12594010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]